| Highly sensitive CE-ESI-MS analysis of N-glycans from complex biological samples GSM Lageveen-Kammeijer, N de Haan, P Mohaupt, S Wagt, M Filius, ... Nature communications 10 (1), 2137, 2019 | 124 | 2019 |
| Methods to discover and validate biofluid-based biomarkers in neurodegenerative dementias CE Teunissen, L Kimble, S Bayoumy, K Bolsewig, F Burtscher, ... Molecular & Cellular Proteomics 22 (10), 2023 | 20 | 2023 |
| β-Synuclein as a candidate blood biomarker for synaptic degeneration in Alzheimer’s disease P Mohaupt, ML Pons, J Vialaret, C Delaby, C Hirtz, S Lehmann Alzheimer's Research & Therapy 14 (1), 179, 2022 | 17 | 2022 |
| Multi-omics interdisciplinary research integration to accelerate dementia biomarker development (MIRIADE) E Mavrina, L Kimble, K Waury, D Gogishvili, N Gómez de San José, S Das, ... Frontiers in Neurology 13, 890638, 2022 | 12 | 2022 |
| Readthrough isoform of aquaporin-4 (AQP4) as a therapeutic target for Alzheimer’s disease and other proteinopathies P Mohaupt, J Vialaret, C Hirtz, S Lehmann Alzheimer's Research & Therapy 15 (1), 170, 2023 | 4 | 2023 |
| The alternative proteome in neurobiology P Mohaupt, X Roucou, C Delaby, J Vialaret, S Lehmann, C Hirtz Frontiers in Cellular Neuroscience 16, 1019680, 2022 | 4 | 2022 |
| Glial fibrillary acidic protein in Alzheimer’s disease: a narrative review F Leipp, J Vialaret, P Mohaupt, S Coppens, A Jaffuel, AC Niehoff, ... Brain Communications 6 (6), fcae396, 2024 | | 2024 |
| Increasing the sensitivity of Simoa via bead count reduction facilitates the quantification of pTau‐181 in dried plasma spots P Mohaupt, J Vialaret, C Hirtz, S Lehmann Alzheimer's & Dementia: Translational Research & Clinical Interventions 10 …, 2024 | | 2024 |
| Plasma α-synuclein domain profiles across α-synucleinopathies ML Pons, P Mohaupt, J Vialaret, E Mondesert, M Vignon, S Coppens, ... medRxiv, 2023.07. 17.23292753, 2023 | | 2023 |
